Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Masitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AB Science: Life Sciences Magazine Features Masitinib, Dr. Vermersch
    AB Science: Life Sciences Magazine Features Masitinib, Dr. Vermersch

    04 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/04/3036186/0/en/AB-Science-Article-from-the-leading-publication-Life-Sciences-Magazine-featuring-masitinib-and-its-Phase-3-principal-investigator-the-neurologist-Patrick-Vermersch.html

    GLOBENEWSWIRE
    04 Mar 2025
    Share Share
    AB Science today provides an update on its masitinib platform
    AB Science today provides an update on its masitinib platform

    29 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/29/3017503/0/en/AB-Science-today-provides-an-update-on-its-masitinib-platform.html

    GLOBENEWSWIRE
    29 Jan 2025
    Share Share
    AB Science Updates On Masitinib In Multiple Sclerosis
    AB Science Updates On Masitinib In Multiple Sclerosis

    23 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/23/2951617/0/en/AB-Science-provides-an-update-on-the-development-of-masitinib-in-progressive-forms-of-multiple-sclerosis-post-ECTRIMS-2024.html

    GLOBENEWSWIRE
    23 Sep 2024
    Share Share
    AB Science announces results of Phase 2 study evaluating masitinib in Covid-19
    AB Science announces results of Phase 2 study evaluating masitinib in Covid-19

    08 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/08/2909366/0/en/AB-Science-announces-positive-results-of-its-Phase-2-study-evaluating-masitinib-in-Covid-19.html

    GLOBENEWSWIRE
    08 Jul 2024
    Share Share
    AB Science Updates On Masitinib Application For ALS
    AB Science Updates On Masitinib Application For ALS

    28 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/28/2905749/0/en/AB-Science-provides-an-update-on-the-application-for-conditional-marketing-authorisation-of-masitinib-in-ALS.html

    GLOBENEWSWIRE
    28 Jun 2024
    Share Share
    AB Science Updates On Masitinib Application For ALS Approval
    AB Science Updates On Masitinib Application For ALS Approval

    29 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/29/2890131/0/en/AB-Science-provides-an-update-on-the-application-for-conditional-marketing-authorisation-of-masitinib-in-ALS.html

    GLOBENEWSWIRE
    29 May 2024
    Share Share